ilShinbiobase Co. Ltd
ilShinbiobase Co. Ltd operates in Diversified Metals & Mining.
ilShinbiobase Co. Ltd (068330) - Net Assets
Latest net assets as of June 2024: ₩58.23 Billion KRW
Based on the latest financial reports, ilShinbiobase Co. Ltd (068330) has net assets worth ₩58.23 Billion KRW as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩60.89 Billion) and total liabilities (₩2.66 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩58.23 Billion |
| % of Total Assets | 95.63% |
| Annual Growth Rate | 8.16% |
| 5-Year Change | 44.54% |
| 10-Year Change | N/A |
| Growth Volatility | 4.44 |
ilShinbiobase Co. Ltd - Net Assets Trend (2016–2023)
This chart illustrates how ilShinbiobase Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ilShinbiobase Co. Ltd (2016–2023)
The table below shows the annual net assets of ilShinbiobase Co. Ltd from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | ₩57.06 Billion | +6.03% |
| 2022-12-31 | ₩53.82 Billion | +7.47% |
| 2021-12-31 | ₩50.08 Billion | +12.85% |
| 2020-12-31 | ₩44.38 Billion | +12.41% |
| 2019-12-31 | ₩39.48 Billion | +12.99% |
| 2018-12-31 | ₩34.94 Billion | +0.14% |
| 2017-12-31 | ₩34.89 Billion | +5.90% |
| 2016-12-31 | ₩32.95 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to ilShinbiobase Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 135.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩50.55 Billion | 88.59% |
| Other Components | ₩6.51 Billion | 11.41% |
| Total Equity | ₩57.06 Billion | 100.00% |
ilShinbiobase Co. Ltd Competitors by Market Cap
The table below lists competitors of ilShinbiobase Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Navidea Biopharmaceuticals Inc
PINK:NAVB
|
$10.01K |
|
Macter International Ltd
KAR:MACTER
|
$10.01K |
|
Olimpo Real Estate SA
MC:YORE
|
$10.02K |
|
808 Renewable Energy Corp
PINK:RNWR
|
$10.02K |
|
Neuralbase AI Ltd.
PINK:VIRAD
|
$9.99K |
|
Water Supply Sewerage Construction and Investment JSC
VN:VSI
|
$9.98K |
|
PGMN3F
SA:PGMN3F
|
$9.98K |
|
CHINA SHINEWAY PHAR (C1S.SG)
STU:C1S
|
$9.98K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ilShinbiobase Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 53,819,218,470 to 57,063,990,100, a change of 3,244,771,630 (6.0%).
- Net income of 6,232,490,530 contributed positively to equity growth.
- Dividend payments of 300,062,980 reduced retained earnings.
- Share repurchases of 2,347,130,730 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩6.23 Billion | +10.92% |
| Dividends Paid | ₩300.06 Million | -0.53% |
| Share Repurchases | ₩2.35 Billion | -4.11% |
| Other Changes | ₩-340.53 Million | -0.6% |
| Total Change | ₩- | 6.03% |
Book Value vs Market Value Analysis
This analysis compares ilShinbiobase Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.07x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.85x to 1.07x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩796.56 | ₩1470.00 | x |
| 2018-12-31 | ₩833.20 | ₩1470.00 | x |
| 2019-12-31 | ₩936.86 | ₩1470.00 | x |
| 2020-12-31 | ₩1035.30 | ₩1470.00 | x |
| 2021-12-31 | ₩1168.29 | ₩1470.00 | x |
| 2022-12-31 | ₩1255.52 | ₩1470.00 | x |
| 2023-12-31 | ₩1369.20 | ₩1470.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ilShinbiobase Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.92%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 37.92%
- • Asset Turnover: 0.27x
- • Equity Multiplier: 1.06x
- Recent ROE (10.92%) is above the historical average (9.30%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 8.16% | 20.15% | 0.35x | 1.14x | ₩-606.84 Million |
| 2017 | 5.98% | 16.40% | 0.33x | 1.09x | ₩-1.42 Billion |
| 2018 | 8.85% | 20.55% | 0.39x | 1.11x | ₩-410.68 Million |
| 2019 | 11.59% | 23.70% | 0.43x | 1.14x | ₩636.81 Million |
| 2020 | 10.09% | 21.29% | 0.42x | 1.12x | ₩40.92 Million |
| 2021 | 11.70% | 24.03% | 0.43x | 1.13x | ₩849.53 Million |
| 2022 | 7.09% | 18.67% | 0.35x | 1.09x | ₩-1.57 Billion |
| 2023 | 10.92% | 37.92% | 0.27x | 1.06x | ₩526.09 Million |
Industry Comparison
This section compares ilShinbiobase Co. Ltd's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $101,285,795,421
- Average return on equity (ROE) among peers: -24.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ilShinbiobase Co. Ltd (068330) | ₩58.23 Billion | 8.16% | 0.05x | $10.00K |
| Kukyoung G&M (006050) | $51.01 Billion | -2.56% | 0.37x | $8.37K |
| Kossen Co Ltd (009730) | $14.31 Billion | -212.62% | 2.32x | $3.71K |
| Haansoft (030520) | $549.72 Billion | 3.28% | 0.54x | $147.64K |
| BIT Computer (032850) | $54.93 Billion | 11.85% | 0.29x | $31.44K |
| Plumb Fast Co (035200) | $29.09 Billion | 11.02% | 0.35x | $21.53K |
| A-Frontier Co. Ltd. (036180) | $25.85 Billion | 16.56% | 0.27x | $3.84K |
| Infraware (041020) | $36.71 Billion | -39.68% | 0.21x | $29.45K |
| Kook Soon Dang Co. Ltd. (043650) | $215.68 Billion | -1.25% | 0.11x | $25.25K |
| Stcube (052020) | $38.70 Billion | -27.66% | 0.51x | $49.27K |
| Fourth-Link Inc. (056730) | $-3.13 Billion | 0.00% | 0.00x | $2.96K |